approval
saveTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 24, 2025 · 314d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 17, 2025 · 321d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalOct 2, 2025 · 367d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalAug 18, 2025 · 412d ago
same company · ±60 days · 6
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalSep 17, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 19, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalSep 20, 2024
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalOct 10, 2024
comments(0)
5-min edit window · permanent after that